Cambridge, Massachusetts-based Vertex Pharmaceuticals Incorporated announced Monday that it has signed a letter of intent with the pan-Canadian…
Charles Moore
Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Charles Moore
A recent study published in the Iranian Journal of Pediatrics suggests that taking probiotics supplements can help improve quality…
In some ways, it’s both the best of times and the worst of times for persons afflicted with certain serious…
Price Of CF Drug Kalydeco Could Drop In Canada And Australia Under New Public Health Care Deals
Canada’s CTV News reported late last week that the province of Alberta’s health minister has successfully negotiated a tentative…
Austin-based International Biophysics Corporation’s marquee product, AffloVest, is a cutting-edge technology airway clearance vest that represents a major advance in…
A new study by researchers at the University of California, San Diego School of Medicine finds that technology helps…
A new study led by a team in the Research Institute at Columbus, Ohio based Nationwide Children’s Hospital…
Complimentary therapeutic approaches are nothing if not controversial in conventional medicine and mainstream organizations offering information and support for…
San Diego State University postdoctoral researcher Katrine Whiteson, Ph. D. has found that a molecule previously linked to lung injuries…
In April 2004, the Food and Drug Administration (FDA) issued a new rule requiring makers of pancreatic enzyme products (PEPs) to…